DRAVET SYNDROME (DS)
Clinical trials for DRAVET SYNDROME (DS) explained in plain language.
Never miss a new study
Get alerted when new DRAVET SYNDROME (DS) trials appear
Sign up with your email to follow new studies for DRAVET SYNDROME (DS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Epilepsy drug study ends early: what we learned about Soticlestat's safety
Disease control TerminatedThis study looked at the long-term safety of soticlestat, an add-on seizure medicine, in children and adults with severe epilepsies like Dravet and Lennox-Gastaut syndromes. About 156 participants took the drug twice daily for as long as it helped them. The study was stopped earl…
Matched conditions: DRAVET SYNDROME (DS)
Phase: PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated May 17, 2026 08:51 UTC
-
Seizure drug safety trial halted early for dravet and Lennox-Gastaut patients
Disease control TerminatedThis study looked at the long-term safety of soticlestat, an add-on seizure medication, in children and adults with Dravet syndrome or Lennox-Gastaut syndrome. Participants took soticlestat along with their usual anti-seizure drugs. The study was terminated early, but the goal wa…
Matched conditions: DRAVET SYNDROME (DS)
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated May 17, 2026 08:49 UTC